Goldman Sachs Investments Mauritius has reportedly offloaded 4.20 lakh shares constituting 0.71% stake of Strides Arcolab through the open market route. The shares were sold on an average price of Rs 876.56 valuing the transaction to Rs 36.82 crore.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
No comments:
Post a Comment